Guardian Capital Advisors LP Johnson & Johnson Transaction History

Guardian Capital Advisors LP

$967 Million
Q3 2024

A detailed history of Guardian Capital Advisors LP transactions in Johnson & Johnson stock. As of the latest transaction made, Guardian Capital Advisors LP holds 96,546 shares of JNJ stock, worth $14.9 Million. This represents 1.62% of its overall portfolio holdings.

Number of Shares

96,546

Previous 96,939 0.41%

Holding current value

$14.9 Million

Previous $14.2 Million 10.43%

% of portfolio

1.62%

Previous 1.61%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$145.48 - $167.38 $57,173 - $65,780	-393 Reduced 0.41%	96,546 $15.6 Million
Q2 2024 Aug 13, 2024	SELL	$144.38 - $157.78 $101,499 - $110,919	-703 Reduced 0.72%	96,939 $14.2 Million
Q1 2024 May 14, 2024	BUY	$155.22 - $162.74 $2,483 - $2,603	16 Added 0.02%	97,642 $15.4 Million
Q4 2023 Feb 08, 2024	SELL	$145.6 - $158.88 $543,524 - $593,099	-3,733 Reduced 3.68%	97,626 $15.3 Million
Q3 2023 Nov 13, 2023	SELL	$155.75 - $174.48 $179,891 - $201,524	-1,155 Reduced 1.13%	101,359 $15.8 Million
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $105,266 - $113,287	682 Added 0.67%	102,514 $17 Million
Q1 2023 May 15, 2023	BUY	$151.05 - $180.26 $159,055 - $189,813	1,053 Added 1.04%	101,832 $15.8 Million
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $85,867 - $96,367	-536 Reduced 0.53%	100,779 $17.8 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $492,863 - $548,433	-3,055 Reduced 2.93%	101,315 $16.5 Million
Q2 2022 Aug 12, 2022	SELL	$168.19 - $186.01 $53,820 - $59,523	-320 Reduced 0.31%	104,370 $18.3 Million
Q1 2022 May 16, 2022	BUY	$158.14 - $179.59 $82,865 - $94,105	524 Added 0.5%	104,690 $18.8 Million
Q4 2021 Feb 10, 2022	SELL	$155.93 - $173.01 $267,731 - $297,058	-1,717 Reduced 1.62%	104,166 $17.7 Million
Q3 2021 Nov 15, 2021	SELL	$161.5 - $179.47 $164,891 - $183,238	-1,021 Reduced 0.96%	105,883 $16.9 Million
Q2 2021 Aug 17, 2021	BUY	$159.48 - $171.07 $201,742 - $216,403	1,265 Added 1.2%	106,904 $18.1 Million
Q1 2021 May 17, 2021	SELL	$153.07 - $170.48 $105,618 - $117,631	-690 Reduced 0.65%	105,639 $16.9 Million
Q4 2020 Feb 12, 2021	BUY	$137.11 - $157.38 $275,728 - $316,491	2,011 Added 1.93%	106,329 $16.8 Million
Q3 2020 Nov 16, 2020	BUY	$140.38 - $153.83 $327,787 - $359,193	2,335 Added 2.29%	104,318 $15.4 Million
Q2 2020 Aug 13, 2020	BUY	$128.81 - $155.51 $643,405 - $776,772	4,995 Added 5.15%	101,983 $10.9 Million
Q1 2020 May 15, 2020	SELL	$111.14 - $153.99 $22,783 - $31,567	-205 Reduced 0.21%	96,988 $8.78 Million
Q4 2019 Feb 13, 2020	BUY	$127.5 - $146.44 $4,972 - $5,711	39 Added 0.04%	97,193 $14.2 Million
Q3 2019 Nov 14, 2019	BUY	$126.95 - $142.14 $83,152 - $93,101	655 Added 0.68%	97,154 $12.8 Million
Q2 2019 Aug 14, 2019	BUY	$131.15 - $144.24 $109,510 - $120,440	835 Added 0.87%	96,499 $13.7 Million
Q1 2019 May 15, 2019	BUY	$125.72 - $139.79 $123,205 - $136,994	980 Added 1.04%	95,664 $13.2 Million
Q4 2018 Feb 13, 2019	SELL	$122.84 - $147.84 $23,216 - $27,941	-189 Reduced 0.2%	94,684 $12.1 Million
Q3 2018 Nov 13, 2018	SELL	$121.58 - $142.88 $102,127 - $120,019	-840 Reduced 0.88%	94,873 $13.2 Million
Q2 2018 Aug 14, 2018	BUY	$119.4 - $131.76 $307,574 - $339,413	2,576 Added 2.77%	95,713 $11.9 Million
Q1 2018 May 15, 2018	BUY	$125.1 - $148.14 $248,949 - $294,798	1,990 Added 2.18%	93,137 $12.2 Million
Q4 2017 Feb 14, 2018	SELL	$131.22 - $143.62 $23,225 - $25,420	-177 Reduced 0.19%	91,147 $13.4 Million
Q3 2017 Nov 15, 2017	BUY	$129.47 - $135.38 $174,655 - $182,627	1,349 Added 1.5%	91,324 $13 Million
Q2 2017 Aug 14, 2017	BUY	N/A	89,975	89,975 $11.9 Million

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $404B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardian Capital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Guardian Capital Advisors LP with notifications on news.

Account

Guardian Capital Advisors LP Johnson & Johnson Transaction History